Managing hope and expectation: Perspectives on HIV cure
HIV cure. Those two little words elicit such hope, expectation and frustration. This was the theme that ran through the series of presentations at the HIV and Sexual Health Conference in August...
HIV Cure Snapshot
The Australasian HIV&AIDS Conference (commonly known as ASHM after the organiser, the Australasian Society for HIV Medicine) was held online from 16-20 November 2020. Here are some highlights of...
Collaborations in Cancer and HIV Cure Research
The HIV Cure & Cancer Forum brought cancer and HIV researchers together in Paris, as a prelude to the International AIDS Society Conference on HIV Science. The forum explored overlaps between the...
Reports of UK HIV cure are misleading
The international media have been at it again this week, with claims of an HIV cure thrown around in a sensationalist click-bait fest, amplified through social media channels and networks around the...
“Shock and kill” strategy reduces virus reservoir during treatment
Researchers have revealed the final results of the REDUC Part B clinical trial to reduce the HIV reservoir in a presentation at the Conference on Retroviruses and Opportunistic Infections (CROI) in...
Widely-used anti-alcoholism drug wakes up dormant HIV-infected cells
An Australian research team has found that disulfiram, a long-established and safe drug used primarily as a treatment for alcohol dependency (and well-known under its brand name Antabuse) can ‘wake...
HIV Latency: A High-Stakes Game of Hide and Seek
The recent case of Scottish nurse Pauline Cafferkey, who relapsed nine months after “clearing” her Ebola infection, has raised concerns that the virus could cause relapsing disease in...
HIV Cure Research: NIH Scientists Create Two-Headed Protein to Deplete HIV Reservoir
WHAT: Scientists at the National Institutes of Health (NIH) have created a protein that awakens resting immune cells infected with HIV and facilitates their destruction in laboratory studies. The...
.png)